Katjana Schwab

Germany
LGSA Member

Deciphering mechanisms for the regulation of the tumor suppressor RFX7

Friedrich Schiller University Jena (FSU): Faculty of Biological Sciences
Leibniz Institute on Aging - Fritz Lipmann Institute (FLI): Hoffmann Research Group

First Supervisor:

Martin Fischer (Leibniz Institute on Aging - Fritz Lipmann Institute (FLI))

Co – Supervisor(s):

Steve Hoffmann (Leibniz Institute on Aging - Fritz Lipmann Institute (FLI))

Doctoral Disputation:

2025

Publications 2025:

  • Gene regulation by convergent promoters.
    Wiechens E, Vigliotti* F, Siniuk* K, Schwarz R, Schwab K, Riege K, van Bömmel A, Görlich I, Bens M, Sahm A, Groth M, Sammons MA, Loewer A, Hoffmann** S, Fischer** M
    Nat Genet 2025, 57(1), 206-17 * equal contribution, ** co-corresponding authors
  • Publications 2024:

    • Inactivation of the DREAM complex mimics the molecular benefits of sleep
      Santos Valentim I, Javier Romero-Expósito F, Schwab K, Bayar M, Tauassarova A, Riege K, Lange L, Engmann O, Fischer M, Olmedo M, Hoffmann S, A.Ermolaeva M
      bioRxiv 2024, https://doi.org/10.1101/2024.06.
    • p53 target ANKRA2 cooperates with RFX7 to regulate tumor suppressor genes.
      Schwab K, Riege K, Coronel L, Stanko C, Förste S, Hoffmann** S, Fischer** M
      Cell Death Discov 2024, 10(1), 376 ** co-corresponding authors

    Publications 2023:

    • Multi-omics analysis identifies RFX7 targets involved in tumor suppression and neuronal processes.
      Schwab K, Coronel L, Riege K, Sacramento EK, Rahnis N, Häckes D, Cirri E, Groth M, Hoffmann S, Fischer M
      CELL DEATH DISCOV 2023, 9(1), 80